Commercial antibodies: the good, bad, and really ugly

J Histochem Cytochem. 2009 Jan;57(1):7-8. doi: 10.1369/jhc.2008.952820. Epub 2008 Oct 14.

Abstract

The range of antibodies available commercially grows ever larger. Perhaps as a consequence, quality control is not always what it could and should be. Investigators must be aware of potential pitfalls and take steps to assure themselves that the specificity of each antibody is as advertised. Additionally, companies should provide the necessary information about the antigen and antibody to investigators, including references, so that the appropriate controls can be included.

MeSH terms

  • Antibodies*
  • Antibodies, Monoclonal
  • Antibody Specificity
  • Quality Control
  • Reagent Kits, Diagnostic / standards*

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Reagent Kits, Diagnostic